Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Bupivacaine for Post-Operative Ureteroscopy Pain
NCT06635889Phase 2Recruiting
- Sponsor
- University of Chicago
- Start
- Mar 2025
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in postoperative pain, sponsored by University of Chicago. Started Mar 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06635889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06635889.